Latest News


See you at Making Pharmaceuticals

See you at Making Pharmaceuticals

ETERNAL is proud to be a contributing organisation at the 2025 edition of the UK and Ireland’s premier event covering all aspects of the pharmaceutical supply chain, Making Pharmaceuticals, taking place at the Ricoh Arena, Coventry, UK on 29th and 30th April 2025.

12 March 2025

6th ICRAPHE - Call for Papers OPEN NOW!

 6th ICRAPHE - Call for Papers OPEN NOW!

We are excited to invite you to the upcoming 6th International Conference on Risk Assessment of Pharmaceuticals in the Environment (ICRAPHE), which will take place on October 20-21, 2025, at the University of Aveiro, Portugal. Abstract submission is open now until July 1st, 2025. Please join us for this exciting event!

11 March 2025

Workshop output available now

Workshop output available now

A short summary of the output from an ETERNAL Industry engagement workshop conducted as part of the Making Pharmaceuticals UK Conference programme held at the Coventry Building Society Arena, Coventry, United Kingdom, on 23rd and 24th April 2024 is now available.

17 June 2024

A roadmap to integrate existing knowledge into pharmaceutical ERA

A roadmap to integrate existing knowledge into pharmaceutical ERA

A key aspect of evaluating the environmental impact and sustainability of pharmaceuticals is assessing the risk that they may pose to ecosystems. A new public report from the ETERNAL project provides an overview of the current EMA regulation covering the environmental risk assessment of pharmaceuticals, followed by a comparison against the new proposed Regulation and Directive published earlier in 2023. The report concludes with a series of recommendations for integrating the latest scientific knowledge into pharmaceutical risk assessment to help fill gaps in the current and proposed legislation.

01 December 2023


This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.